CRIS
Price
$1.62
Change
+$0.04 (+2.53%)
Updated
Apr 25, 11:42 AM (EDT)
Capitalization
16.53M
OCX
Price
$3.39
Change
+$0.44 (+14.92%)
Updated
Apr 24 closing price
Capitalization
24.2M
Ad is loading...

CRIS vs OCX

Header iconCRIS vs OCX Comparison
Open Charts CRIS vs OCXBanner chart's image
Curis
Price$1.62
Change+$0.04 (+2.53%)
Volume$305
Capitalization16.53M
Oncocyte
Price$3.39
Change+$0.44 (+14.92%)
Volume$170.14K
Capitalization24.2M
CRIS vs OCX Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. OCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Buy and OCX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CRIS: $1.58 vs. OCX: $3.39)
Brand notoriety: CRIS and OCX are both not notable
CRIS represents the Biotechnology, while OCX is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRIS: 61% vs. OCX: 214%
Market capitalization -- CRIS: $16.53M vs. OCX: $24.2M
CRIS [@Biotechnology] is valued at $16.53M. OCX’s [@Medical Specialties] market capitalization is $24.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileOCX’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • OCX’s FA Score: 0 green, 5 red.
According to our system of comparison, OCX is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 4 TA indicator(s) are bullish while OCX’s TA Score has 6 bullish TA indicator(s).

  • CRIS’s TA Score: 4 bullish, 4 bearish.
  • OCX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OCX is a better buy in the short-term than CRIS.

Price Growth

CRIS (@Biotechnology) experienced а +20.61% price change this week, while OCX (@Medical Specialties) price change was +19.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.06%. For the same industry, the average monthly price growth was -4.28%, and the average quarterly price growth was -12.50%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

OCX is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+7.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCX($24.2M) has a higher market cap than CRIS($16.5M). OCX YTD gains are higher at: 42.437 vs. CRIS (-48.366). OCX has higher annual earnings (EBITDA): -10.44M vs. CRIS (-44.56M). CRIS has more cash in the bank: 20.9M vs. OCX (14.2M). OCX has less debt than CRIS: OCX (3.07M) vs CRIS (3.26M). CRIS has higher revenues than OCX: CRIS (10.3M) vs OCX (1.46M).
CRISOCXCRIS / OCX
Capitalization16.5M24.2M68%
EBITDA-44.56M-10.44M427%
Gain YTD-48.36642.437-114%
P/E RatioN/A4.56-
Revenue10.3M1.46M704%
Total Cash20.9M14.2M147%
Total Debt3.26M3.07M106%
FUNDAMENTALS RATINGS
CRIS vs OCX: Fundamental Ratings
CRIS
OCX
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9743
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCX's Valuation (55) in the Medical Specialties industry is in the same range as CRIS (66) in the Biotechnology industry. This means that OCX’s stock grew similarly to CRIS’s over the last 12 months.

OCX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CRIS (100) in the Biotechnology industry. This means that OCX’s stock grew similarly to CRIS’s over the last 12 months.

OCX's SMR Rating (97) in the Medical Specialties industry is in the same range as CRIS (99) in the Biotechnology industry. This means that OCX’s stock grew similarly to CRIS’s over the last 12 months.

OCX's Price Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for CRIS (97) in the Biotechnology industry. This means that OCX’s stock grew somewhat faster than CRIS’s over the last 12 months.

OCX's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as CRIS (100) in the Biotechnology industry. This means that OCX’s stock grew similarly to CRIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISOCX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIAF0.510.02
+3.50%
bioAffinity Technologies
GTE4.570.14
+3.16%
Gran Tierra Energy
RUSHA52.261.26
+2.47%
Rush Enterprises
FUBO2.990.07
+2.40%
fuboTV
HIG119.240.19
+0.16%
The Hartford Insurance Group Inc.

OCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCX has been loosely correlated with STRRP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OCX jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCX
1D Price
Change %
OCX100%
+14.92%
STRRP - OCX
37%
Loosely correlated
-1.96%
FATE - OCX
31%
Poorly correlated
+1.50%
GOSS - OCX
29%
Poorly correlated
+9.43%
BMRN - OCX
29%
Poorly correlated
+1.29%
CRIS - OCX
28%
Poorly correlated
+5.33%
More